Healthcare -
Biotechnology - NASDAQ - US
$ 0.8701
-3.96 %
$ 39.8 M
Market Cap
-0.56
P/E
XLO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities XLO - Xilio Therapeutics, Inc.
-6.55 M
LAST VALUE
-1.25%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR